搜尋結果
Lilly Invests Over $5 Billion to Boost Weight-Loss Drug Supply
Bloomberg· 3 小時前Have a confidential tip for our reporters? Eli Lilly & Co. will spend $5.3 billion to boost ...
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Reuters· 2 小時前, opens new tab said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana ...
Weight-Loss Drug Zepbound May Also Treat Obstructive Sleep Apnea. Here’s What To Know About The ...
Forbes· 5 日前A clinical trial is underway to evaluate the efficacy of Zepbound, a popular weight-loss< ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 2 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking ...
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
CNBC· 3 小時前Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in ...
Many Quit Weight-Loss Drugs Too Early for Benefits, Insurer Says
Bloomberg· 3 日前Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 ...
Opinion | Switch Off ‘Stress Chemicals’ to Lose Weight—and Keep It Off
The Wall Street Journal· 5 日前My collaborators at the University of California, San Francisco, and I developed a skill set, ...
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro - English News - ...
metroradio.com.hk· 3 日前Australia said on Wednesday it will ban copies of drugs used for weight loss such ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 3 日前Have a confidential tip for our reporters? China gave the greenlight to Eli Lilly & Co.’s ...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters· 6 小時前, opens new tab Ozempic slowed the worsening of kidney dysfunction in patients with type 2 ...